ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV.— 510(k) K832058

Substantially Equivalent

Parke-Davis Co.

FDA 510(k) clearance K832058 for ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV., Substantially Equivalent on 1983-09-12. Applicant: Parke-Davis Co..

Clearance details

Applicant: Parke-Davis Co.
Product code: Code KRA
Advisory panel: Cardiovascular
Date received: 1983-06-27
Decision date: 1983-09-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code KRA

product code KRA

Death: 234
Injury: 1,029
Malfunction: 3,012
Other: 2
Total: 4,277

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.